Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Johnson

    Tag: Johnson

    You Searched For "Johnson"
    New tests shows NO sign of asbestos in recalled JnJ baby powder

    New tests shows NO sign of asbestos in recalled JnJ baby powder

    Medical Dialogues Bureau30 Oct 2019 1:18 PM IST
    But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Johnson and Johnson hit with whooping USD 8 billion verdict over antipsychotic drug Risperda

    Medical Dialogues Bureau9 Oct 2019 4:24 PM IST
    Johnson and Johnson said the award was "grossly disproportionate with the initial compensatory award in this case, and the company is confident it...
    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    JnJ pledges USD 500 million investment to eliminate HIV, TB by 2030

    Medical Dialogues Bureau7 Oct 2019 9:30 AM IST
    NEW BRUNSWICK: Johnson & Johnson (JnJ) recently announced it has committed to ensuring more than $500 million is dedicated to world-class research...
    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    GSK receives USFDA panel backing for OTC nicotine oral spray for smoking de-addiction

    Farhat Nasim19 Sept 2019 9:30 AM IST
    Johnson & Johnson (JnJ), GSK Plc's developmental partner, sell the over-the-counter nicotine oral spray in 45 countries, excluding the United...
    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Former JnJ executive Marianne De Backer to lead Bayer pharma division

    Medical Dialogues Bureau4 Sept 2019 9:30 AM IST
    Marianne De Backer will take the role of Head of Business Development & Licensing at Bayer's pharmaceuticals division, joining from rival JnJ,...
    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Allergan, Endo agree to USD 15 million settlement in major opioid case

    Medical Dialogues Bureau24 Aug 2019 9:00 AM IST
    Allergan has tentatively agreed to pay $5 million to resolve claims involving its branded opioids, though the deal does not resolve claims involving...
    Oklahoma judge denies motion to end case against drugmaker JnJ

    Oklahoma judge denies motion to end case against drugmaker JnJ

    Medical Dialogues Bureau9 July 2019 9:00 AM IST
    District Judge Thad Balkman denied Johnson & Johnson lawyers' motion asking him to end the case mid-trial and rule in favour of the New Brunswick,...
    GSK offers concessions to address Pfizer deal concerns

    GSK offers concessions to address Pfizer deal concerns

    Farhat Nasim23 Jun 2019 8:59 AM IST
    GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Union Health Minister asked not to receive donations from JnJ for TB Control Program

    Medical Dialogues Bureau3 May 2019 9:15 AM IST
    Recently, Johnson & Johnson (JnJ) had announced to provide an additional 10,000 courses of tuberculosis drug bedaquiline (BDQ) to the Indian...
    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    CDSCO to hire 754 Regulatory Officers especially to regulate Medical Devices in country:DTAB

    Meghna A Singhania27 April 2019 3:00 PM IST
    New Delhi: With the various controversies relating to medical devices taking the limelight, the Government is looking forward to recruiting 754...
    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    MORE TEARS: After Talcum Powder, JnJ Baby Shampoo reveals presence of Carcinogens

    Meghna A Singhania3 April 2019 4:30 PM IST
    New Delhi: After facing trouble with its baby talcum powder amid allegations that it contains asbestos, US healthcare giant Johnson and Johnson (JnJ)...
    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    Meghna A Singhania30 March 2019 1:15 PM IST
    Mumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok